PuSH - Publikationsserver des Helmholtz Zentrums München

Kalla, D.* ; Flisikowski, K.* ; Yang, K. ; Sangüesa, L.B.* ; Kurome, M.* ; Kessler, B.* ; Zakhartchenko, V.* ; Wolf, E.* ; Lickert, H. ; Saur, D.* ; Schnieke, A.* ; Flisikowska, T.*

The missing link: Cre pigs for cancer research.

Front. Oncol. 11:755746 (2021)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The Cre/loxP system is a powerful tool for the generation of animal models with precise spatial and temporal gene expression. It has proven indispensable in the generation of cancer models with tissue specific expression of oncogenes or the inactivation of tumor suppressor genes. Consequently, Cre-transgenic mice have become an essential prerequisite in basic cancer research. While it is unlikely that pigs will ever replace mice in basic research they are already providing powerful complementary resources for translational studies. But, although conditionally targeted onco-pigs have been generated, no Cre-driver lines exist for any of the major human cancers. To model human pancreatic cancer in pigs, Cre-driver lines were generated by CRISPR/Cas9-mediated insertion of codon-improved Cre (iCre) into the porcine PTF1A gene, thus guaranteeing tissue and cell type specific function which was proven using dual fluorescent reporter pigs. The method used can easily be adapted for the generation of other porcine Cre-driver lines, providing a missing tool for modeling human cancers in large animals.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
6.244
1.251
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cell Fate ; Genome Editing ; Icre Recombinase ; Pancreatic Cancer ; Pig ; Ptf1a ; Translational Model; Ptf1a; Recombinase; Expression; Promoter; Models
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 2234-943X
e-ISSN 2234-943X
Zeitschrift Frontiers in Oncology
Quellenangaben Band: 11, Heft: , Seiten: , Artikelnummer: 755746 Supplement: ,
Verlag Frontiers
Verlagsort Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Begutachtungsstatus Peer reviewed
POF Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-231
G-502300-001
Scopus ID 85117560561
PubMed ID 34692545
Erfassungsdatum 2021-12-09